首页> 外文OA文献 >C6-01: Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

【2h】

C6-01: Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

机译：C6-01：培美曲塞加顺铂或吉西他滨加顺铂在局部晚期或转移性非小细胞肺癌（NSCLC）患者中的培美曲塞联合顺铂或吉西他滨联合顺铂的大型III期试验中生物标志物表达与临床结果的相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Scagliotti Giorgio; Kaiser Christopher; Biesma Bonne; Manegold Christian; Gatzemeier Ulrich; Serwatowski Piotr; Syrigos Kostas; Balint Beatrix; Smit Hans J.; Vansteenkiste Johan;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 1BA Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) [J] . C.Manegold, R.Digumarti, M.Zukin, European Journal of Cancer Supplements . 2007,第6期

机译：1BA培美曲塞联合顺铂与吉西他滨联合顺铂在局部晚期或转移性非小细胞肺癌（NSCLC）化疗阳性患者中的IIIBA研究
2. Phase 111 study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) [J] . C. Manegold, R. Digumarti, M. Zukin, European Journal of Cancer Supplements . 2007,第6期

机译：培美曲塞加顺铂与吉西他滨加顺铂在局部晚期或转移性非小细胞肺癌（NSCLC）化疗阳性患者中的111期研究
3. Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with advanced non-small cell lung cancer. [J] . Novello S, Pimentel FL, Douillard JY, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第10期

机译：非小细胞肺癌组织学的安全性和资源利用：培美曲塞加顺铂与吉西他滨加顺铂在晚期非小细胞肺癌化疗放化疗患者中进行的随机III期研究结果。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001 [O] . Kana Watanabe, Yukihiro Toi, Atsushi Nakamura, 2021

机译：尿嘧啶/ TEGAFUR和顺铂的随机期II试验与培养基和顺铂具有同时胸部放射治疗用于局部先进的不可切除阶段III非鳞状非小细胞肺癌：NJLCG1001
7. PRS-03: Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) [O] . Scagliotti Giorgio, Purvish Parikh, von Pawel Joachim, 2007

机译：PRS-03：培美曲塞加顺铂与吉西他滨加顺铂在局部晚期或转移性非小细胞肺癌（NSCLC）化疗阳性患者中的III期研究

C6-01: Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅